The fatty-acid amide hydrolase inhibitor URB597 does not affect triacylglycerol hydrolysis in rat tissues
Open Access
- 29 June 2006
- journal article
- Published by Elsevier in Pharmacological Research
- Vol. 54 (5) , 341-344
- https://doi.org/10.1016/j.phrs.2006.06.008
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Pharmacological Profile of the Selective FAAH Inhibitor KDS-4103 (URB597)CNS Drug Reviews, 2006
- CANNABINOID RECEPTORS AS THERAPEUTIC TARGETSAnnual Review of Pharmacology and Toxicology, 2006
- Fat Mobilization in Adipose Tissue Is Promoted by Adipose Triglyceride LipaseScience, 2004
- Reversible Inhibitors of Fatty Acid Amide Hydrolase That Promote Analgesia: Evidence for an Unprecedented Combination of Potency and SelectivityThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Cyclohexylcarbamic Acid 3‘- or 4‘-Substituted Biphenyl-3-yl Esters as Fatty Acid Amide Hydrolase Inhibitors: Synthesis, Quantitative Structure−Activity Relationships, and Molecular Modeling StudiesJournal of Medicinal Chemistry, 2004
- Discovering potent and selective reversible inhibitors of enzymes in complex proteomesNature Biotechnology, 2003
- Design, Synthesis, and Structure−Activity Relationships of Alkylcarbamic Acid Aryl Esters, a New Class of Fatty Acid Amide Hydrolase InhibitorsJournal of Medicinal Chemistry, 2003
- An anorexic lipid mediator regulated by feedingNature, 2001
- Purification and Characterization of a Porcine Liver Microsomal Triacylglycerol HydrolaseBiochemistry, 1997
- Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amidesNature, 1996